NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ourania TatsisEVP Chief Reg. Quality Off.2026-01-074,500$474.99
$2.14MSell
Charles F. Wagner Jr.EVP CO FO2026-01-069,532$189.38
$1.81MBuy
Charles F. Wagner Jr.EVP CO FO2026-01-069,532$461.00
$4.39MSell
Jeffrey M. LeidenExecutive Chairman2025-12-041$91.05
$91.05Buy
Ourania TatsisEVP Chief Reg. Quality Off.2025-12-034,500$449.99
$2.02MSell
Jeffrey M. LeidenExecutive Chairman2025-12-034,469$440.40
$1.97MSell
Jeffrey M. LeidenExecutive Chairman2025-12-031,320$441.26
$582.46kSell
Jonathan BillerEVP and Chief Legal Officer2025-12-03347$449.00
$155.80kSell
Jeffrey M. LeidenExecutive Chairman2025-12-032,469$443.21
$1.09MSell
Jeffrey M. LeidenExecutive Chairman2025-12-034,352$444.36
$1.93MSell

1 of 11

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors10.21%25,910,587$11.45BInstitution
Vanguard Group Inc9.54%24,216,865$10.71BInstitution
Blackrock Inc8.77%22,253,047$9.84BInstitution
Capital Research Global Investors6.52%16,553,281$7.32BInstitution
State Street Corp4.57%11,606,000$5.13BInstitution
Jpmorgan Chase Co2.54%6,434,778$2.84BInstitution
Geode Capital Management LLC2.35%5,973,745$2.64BInstitution
Wellington Management Group LLP1.88%4,772,042$2.11BInstitution
Capital International Investors1.85%4,689,059$2.07BInstitution
Alliancebernstein LP1.78%4,522,586$2.00BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX91.40%1.51%Net SellingNet Selling
REGN68.26%31.74%Net SellingNet Selling
ARGX50.00%0.00%
ALNY82.79%17.21%Net SellingNet Selling
ONC2.29%32.05%Net BuyingNet Selling

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 91.40% institutional shareholders, 1.51% Vertex Pharmaceuticals insiders, and 7.09% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 25.91M shares representing 10.21% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $11.95B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.